UFC Signee Fails Drug Test After DWCS Knockout
UFC signee Igor Cavalcanti tested positive for a banned substance following his knockout victory at Dana White's Contender Series in September, the Nevada Athletic Commission announced this week.
Cavalcanti, who flattened Oscar Ravello in 89 seconds on Sept. 15, returned a positive result for 19-Norandrosterone, a metabolite of the anabolic steroid nandrolone. He is currently suspended pending a final ruling from the commission, which has not yet decided whether to overturn the result or what additional penalties the middleweight might face.
Cavalcanti's Team Claims Medical Exception
Manager Lucas Lutkus told MMA Fighting that Cavalcanti had disclosed his nandrolone use to the UFC before the failed test. According to Lutkus, the Brazilian received three 25-milligram intramuscular injections between late February and early March to treat a knee injury involving a torn meniscus and cartilage damage. "At the time, Igor was preparing for a fight in Europe and had no knowledge that he would be competing in the UFC approximately six months later," Lutkus said in a statement first carried by MMA Junkie.
Lutkus added that All In Sports Management, which began representing Cavalcanti in June after the treatment ended, has worked with the fighter's medical team to compile documentation for the commission. "Igor had previously disclosed his nandrolone use to the UFC and made no attempt to conceal the treatment," Lutkus wrote.
Cavalcanti earned his UFC contract with the September stoppage after losing on the Contender Series in 2024 to Seok Hyeon Ko. He won four of five fights outside the UFC before returning to the octagon. His status under contract is uncertain as the commission weighs its final decision.
Photo by Jonathan Tomas on Unsplash
Original reporting:
Get Ringside Updates
Fight announcements, results, and analysis delivered to your inbox. No spam. Unsubscribe anytime.
Join the discussion
Loading the discussion…